| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | fn3 | 4.01e-03 | 162 | 37 | 3 | PF00041 | |
| Domain | FN3 | 5.80e-03 | 185 | 37 | 3 | SM00060 | |
| Domain | FN3 | 7.09e-03 | 199 | 37 | 3 | PS50853 | |
| Domain | FN3_dom | 8.11e-03 | 209 | 37 | 3 | IPR003961 | |
| Domain | Rho_GTPase_activation_prot | 1.31e-02 | 88 | 37 | 2 | IPR008936 | |
| Pubmed | A chondroplastic, brachymorphic and stubby chondrodystophies in mice. | 1.16e-06 | 2 | 38 | 2 | 939824 | |
| Pubmed | IGF2/IGF2R/Sting signaling as a therapeutic target in DSS-induced ulcerative colitis. | 1.16e-06 | 2 | 38 | 2 | 37863414 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 624676 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 5713631 | ||
| Pubmed | 7.62e-06 | 250 | 38 | 5 | 33536335 | ||
| Pubmed | 1.56e-04 | 17 | 38 | 2 | 15944189 | ||
| Pubmed | The contribution of de novo coding mutations to autism spectrum disorder. | 1.76e-04 | 18 | 38 | 2 | 25363768 | |
| Pubmed | 1.83e-04 | 777 | 38 | 6 | 35844135 | ||
| Pubmed | 2.03e-04 | 104 | 38 | 3 | 9205841 | ||
| Pubmed | Discovery and characterization of spontaneous mouse models of craniofacial dysmorphology. | 2.41e-04 | 21 | 38 | 2 | 26234751 | |
| Pubmed | 3.43e-04 | 25 | 38 | 2 | 27621311 | ||
| Pubmed | 6.77e-04 | 650 | 38 | 5 | 38777146 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 7.90e-04 | 1425 | 38 | 7 | 30948266 | |
| Pubmed | A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export. | 8.67e-04 | 392 | 38 | 4 | 33144569 | |
| Pubmed | 1.01e-03 | 1487 | 38 | 7 | 33957083 | ||
| Pubmed | An Interaction Network of the Human SEPT9 Established by Quantitative Mass Spectrometry. | 1.02e-03 | 43 | 38 | 2 | 30975701 | |
| GeneFamily | Fibronectin type III domain containing | 1.06e-03 | 160 | 23 | 3 | 555 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.17e-05 | 165 | 38 | 4 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.17e-05 | 165 | 38 | 4 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-05 | 167 | 38 | 4 | a48349f189f6a8d563744b0a294c3974f3a18f50 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-05 | 173 | 38 | 4 | 6c9ecf77d2fb0f89100fdd7e4e88f85598278bc7 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.61e-05 | 179 | 38 | 4 | 4f20540bfbcefe0e83812be7ea542e8bb3bf19bc | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.72e-05 | 182 | 38 | 4 | 14a117c5e50db31ee1b2cf4df4d133451fd6d55f | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.21e-05 | 194 | 38 | 4 | b30379f8dc41c86c746af9930541fbb4819d8fa0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 196 | 38 | 4 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 196 | 38 | 4 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.44e-05 | 199 | 38 | 4 | e9009eee7f77b9c9917f8e0e723001d9e76eb553 | |
| Disease | Moyamoya Disease | 2.06e-04 | 17 | 37 | 2 | C0026654 | |
| Disease | Drugs used in diabetes use measurement | 2.88e-04 | 255 | 37 | 4 | EFO_0009924 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RPFLKPGYRHHLIPS | 141 | Q8IYW2 | |
| GLAPHLTHYADLLPG | 376 | Q9BQC3 | |
| DLKLYHDPDLLLGPG | 86 | P20594 | |
| LHLGKPGHRSYALSP | 416 | P54253 | |
| YENIHLARLGPPAHK | 281 | Q5SQ64 | |
| GAPGLRHFLYKPLDI | 406 | Q7L1V2 | |
| ERGYKHPVLLLHPLG | 431 | O95340 | |
| GHPLSPERDHLEGLY | 986 | Q8TEW8 | |
| PYVHLAPHALDRGLG | 261 | Q8NCK7 | |
| LKIGGEPHISYPPLH | 291 | P43356 | |
| HHKIAYRPPGQELGV | 781 | Q5SZK8 | |
| LLYPCIDRHLGEPHK | 86 | Q9Y5U4 | |
| VREHGPEHPLPRLKY | 691 | O95672 | |
| DPQGLGLHFYKHGEP | 941 | O75694 | |
| ALLPHPPFEYHLGRK | 41 | Q8N7S2 | |
| LNDSKKGPPHLHYRR | 301 | Q8IZD9 | |
| KPYHPRLPALEHDEG | 1976 | Q8IZD9 | |
| EHDPLKGRLSYPHPG | 266 | Q7Z5Q1 | |
| KYLAHGLPAGAPLRL | 206 | A5D6W6 | |
| KHPPEDGVFIHGLFL | 3916 | Q8WXX0 | |
| GHLKLPGLRTYVDPH | 586 | P29320 | |
| PGKPLFHLEHYIEGK | 221 | O00418 | |
| KAHRPGDLIHLPPYL | 1891 | O60469 | |
| DPRHGNLYDLKPLGL | 1231 | P11717 | |
| YGPKIDVHLHDALGR | 536 | Q9BW92 | |
| LGEPPEHTLRYLVLH | 36 | Q86WV6 | |
| LLGYLKHYRNIPGPH | 221 | P28370 | |
| RDLHHAPLLPLYDGT | 51 | Q8IUH8 | |
| VHHERKYGPRLAPLL | 161 | Q7Z5H3 | |
| YGLGSKKHPLHLLIP | 206 | Q8N999 | |
| PIGGIDHKPRDGFHL | 4531 | Q63HN8 | |
| GEPRGPLNHLYRELK | 256 | Q9H900 | |
| DLKHPEGRGHLLYVA | 841 | O15067 | |
| KLLLYGLHHGKRVGP | 1841 | P22105 | |
| VGHLLKGYRHPSPAI | 2391 | P21359 | |
| LKPGDLLYFPRGTIH | 226 | Q8IUF8 | |
| HRGREVGKDLPYPGL | 121 | Q86TA4 | |
| LHPDHLPRTDGVKYE | 761 | Q9ULT6 | |
| LEHPLLLEPGHRKFD | 186 | Q8NG68 | |
| PIPKRDLLYHLHGGD | 426 | Q68DK2 | |
| YELHGPHAAPKLLKA | 101 | P0DJG4 | |
| LPGHQRIHTGEKPYI | 536 | Q96RE9 |